RT @DrLoriBrotto: @BusinessOfSex @cindypinkceo @SproutPharma For the record, I wrote "flibanserin will be px by non-expert physicians seein…
@BusinessOfSex @cindypinkceo @SproutPharma For the record, I wrote "flibanserin will be px by non-expert physicians seeing a much broader range of sexual desire difficulties...Not only might complementing a script with sex ed & therapy be useful, it wi
#Flibanserin #Addyi the female desire drug hopes to be an integral part of combination therapy https://t.co/zWzBCpQ0v0
#Flibanserin #Addyi the female desire drug hopes to be an integral part of combination therapy https://t.co/GaCGqTUpNw
RT @DrMorgentaler: Interesting new take on the possibilities ahead to treat sexual dysfunction with #flibanserin https://t.co/kvNcfTcPfd
Hopefully the approval of Addyi will encourage practitioners to consider combination treatments for sexual function. https://t.co/t28fqIisdQ
Interesting new take on the possibilities ahead to treat sexual dysfunction with #flibanserin https://t.co/kvNcfTcPfd
It's about me! #Flibanserin scientifically assessed https://t.co/CeF77cPhk1
RT @AliceDreger: Interesting. @DrLoriBrotto argues flibanserin offers an opportunity. https://t.co/kROOoHPRUj
RT @AmyMuise: Great editorial on #flibanserin @DrLoriBrotto https://t.co/k5o2icy47h
RT @AliceDreger: Interesting. @DrLoriBrotto argues flibanserin offers an opportunity. https://t.co/kROOoHPRUj
RT @AliceDreger: Interesting. @DrLoriBrotto argues flibanserin offers an opportunity. https://t.co/kROOoHPRUj
RT @AmyMuise: Great editorial on #flibanserin @DrLoriBrotto https://t.co/k5o2icy47h
Interesting. @DrLoriBrotto argues flibanserin offers an opportunity. https://t.co/kROOoHPRUj
Great editorial on #flibanserin @DrLoriBrotto https://t.co/k5o2icy47h